Remotely triggered drug delivery devices have recently been realized as injectable or implantable formulations that enable the patient or physician to control the timing and dose of drug release over an extended period. Such devices could increase patient compliance, maximize therapeutic effectiveness and minimize side effects. They can be triggered by near-infrared (NIR) light, which can harmlessly and painlessly pass through tissue at controlled doses and exposure times. We discuss the use of NIR-triggered devices and materials, with examples. Safety issues and future prospects are also addressed.
No takes yet. Share an insight, caveat, or question.
Timko et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: